GlassScriptPrepare for your visit
Andrew D Lee
Dermatology · Elkin, NC · NPI 1518154889
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$702,435.87
in general payments reported to CMS, 2019-2025 · $117K in 2025
The $117K reported for 2025 was more than what 98% of Dermatology providers received nationally (typical 2025 total: $772).
Who reported paying
General payments only, top 6 by amount.
- Abbvie INC. $263,197.86
- Amgen INC. $101,739.15
- Dermavant Sciences, INC. $97,388.15
- Genzyme Corporation $64,678.87
- Regeneron Healthcare Solutions, INC. $55,457.99
- Galderma Laboratories, L.P. $46,597.89
Drugs and devices associated with these payments
Dupixent Vtama Otezla Nemluvio Skyrizi Rinvoq Opzelura Aklief Tremfya Bimzelx Adbry Taltz
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Andrew Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/204096/andrew-d-lee